Why the study?
Can the Biostator GCIIS maintain satisfactory glucose clamps at various levels in normal subjects?
Can the Biostator GCIIS maintain satisfactory glucose clamps at various levels in normal subjects?
The Biostator GCIIS can maintain satisfactory glucose clamps for 2 hours in normal subjects, despite some technical limitations requiring supplementary glucose infusion.
No takes yet. Share an insight, caveat, or question.
Biostator GCIIS may enable short-term glucose clamps in research; leaves open reliability and utility in patients or longer protocols.
Verdonk et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: